Founded Date: 2011-01-01
Last Funding Type: Series E
Headquarters: Emeryville, California, United States
Investors Number: 14.0
Technology: Biopharma, Biotechnology, Genetics, Health Care, Therapeutics
Employee Number: 101-250
Industry: Preclinical Development
Estimated Revenue: $50M to $100M
Last Funding Date: 2018-10-10
Funding Status: IPO
Total Funding: 267567756.0